Chronic Pulmonary Aspergillosis clinical trials

Explore recruiting chronic pulmonary aspergillosis clinical trials.

Recruiting chronic pulmonary aspergillosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Pulmonary Aspergillosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole alone in non- or mildly- immunocompromised patients with Chronic Pulmonary Aspergillosis: a prospective, randomized, single blind study, (single aspergilloma excluded).

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, monocentric, prospective, nonrandomized, open-label, experimental study to evaluate efficacy and safety of intrabronchial instillation of liposomal Amphotericin B in patients with simple pulmonary aspergilloma.

Latvia

Therapeutic exploratory (Phase II) EU CTIS Study details

Nebulised lIposomal aMphotericin B in chronic pUlmonary aSpergillosis: a deposition study

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options

Hungary, Belgium, Austria, Germany, Netherlands, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Pulmonary Aspergillosis trials by city

Chronic Pulmonary Aspergillosis in Toronto Chronic Pulmonary Aspergillosis in Vancouver Chronic Pulmonary Aspergillosis in Montreal Chronic Pulmonary Aspergillosis in Calgary Chronic Pulmonary Aspergillosis in Edmonton Chronic Pulmonary Aspergillosis in Ottawa Chronic Pulmonary Aspergillosis in Winnipeg Chronic Pulmonary Aspergillosis in Quebec City Chronic Pulmonary Aspergillosis in Hamilton Chronic Pulmonary Aspergillosis in Kitchener Chronic Pulmonary Aspergillosis in London Chronic Pulmonary Aspergillosis in Halifax Chronic Pulmonary Aspergillosis in New York Chronic Pulmonary Aspergillosis in Los Angeles Chronic Pulmonary Aspergillosis in Chicago Chronic Pulmonary Aspergillosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease